Immediate Effects of the HVLA Talocrural Distraction Technique in Soccer Players

October 20, 2024 updated by: Isidro Fernández López, Universidad Complutense de Madrid

Immediate Effects of the HVLA Talocrural Distraction Technique in Dorsiflexion, the Plantar Center of Pressure and the Percentage of Rearfoot Loading in Soccer Players

This clinical trial aims to evaluate the effect of a high-speed, low-amplitude physiotherapy technique at the ankle level, when performed on amateur soccer players.

Study Overview

Detailed Description

In this randomized, single-blind, cross-sectional and prospective clinical trial, the effect on ankle mobility and changes in plantar pressure centers obtained after performing a high-velocity, low-amplitude physiotherapy technique in amateur soccers will be assessed.

Two intervention groups are used; in one of them this treatment will be applied in a real way, and in the other one a simulation will be carried out.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Isidro Fernández-López, PT PhD
  • Phone Number: +34 625598970
  • Email: isidrofe@ucm.es

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Men over 18 years old
  • Men that played or have played soccer as an amateur or professional on a regular basis
  • No previous musculoskeletal history that would contraindicate HLVA techniques (recent fractures, osteosynthesis material placed in the joint, infections...)

Exclusion Criteria:

  • Subjects under 18 years old
  • Subjects who have suffered musculoskeletal pathology in the lower limb that contraindicates manipulation or who have a medical diagnosis of chronic ankle instability
  • Subjects who suffer neurological or cognitive alterations that prevent the understanding of questionnaires or physical tests; and those who have not signed the informed consent documents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
high-speed, low-amplitude talocrural decompression technique and changes at the level of mobility and plantar pressure
high-speed, low-amplitude talocrural decompression technique and changes at the level of mobility and plantar pressure in a supine position
Active Comparator: Active Comparator
simulated ankle technique and changes at the level of mobility and plantar pressure
simulated ankle technique in a supine position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ankle range of motion
Time Frame: one day
ankle dorsiflexion mobility with a manual dorsiflexion mobility test
one day
plantar pressure centers
Time Frame: one day
plantar pressure centers using stabilometric platform
one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2024

Primary Completion (Estimated)

January 11, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

October 20, 2024

First Submitted That Met QC Criteria

October 20, 2024

First Posted (Actual)

October 22, 2024

Study Record Updates

Last Update Posted (Actual)

October 22, 2024

Last Update Submitted That Met QC Criteria

October 20, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UComplutenseMadrid HVLA ankle

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Injury

Subscribe